Publications
- Corbett RJ, Kaufman RS, McQuaid SW, Vaksman Z, Phul S, Brown MA, Mason JL, Waszak SM, Zhang B, Zhong C, Blauel E, Desai H, Hausler R, Naqvi AS, Daggett JM, Sickler A, Cresswell-Clay EC, Sullivan PJ, Chroni A, Geng Z, Gonzalez EM, Zhu Y, Heath AP, Li M; Penn Medicine BioBank; Regeneron Genetics Center; Storm PB, Resnick AC, Maxwell KN, Cole KA, Waanders AJ, Bornhorst M, MacFarland SP, Rokita JL, Diskin SJ (in press). Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric CNS tumors. Nature Communications, accepted 10/9/25.
- Modi, A., Blauel, E., Diskin, S.J. (2024). Genetic Predisposition. In: Asgharzadeh, S., Westermann, F. (eds) Neuroblastoma. Pediatric Oncology. Springer, Cham.
- Emily Blauel-Bocko et al., Vincristine (VCR) pharmacokinetics (PK) in infants dosed using a body surface area (BSA) banded dosing table and in older children dosed based on BSA: A pediatric early phase clinical trial network study (PEPN22P1). JCO 42, 10015-10015(2024).
- Blauel ER, Laetsch TW. “The promise of TRK inhibitors in pediatric cancers with NTRK fusions.” Cancer Genet. 2022;262-263:71-79. [PMID: 35108663]
Practice Locations
Children's Hospital Colorado Anschutz Medical Campus13123 East 16th Ave
Aurora, CO 80045
720-777-1234